A core challenge in the analysis of experimental data is that the impact of some intervention is often not entirely captured by a single, well-defined outcome. Instead there may be a large number of outcome variables that are potentially affected and of interest. In this paper, we propose a data-driven approach rooted in machine learning to the problem of testing effects on such groups of outcome variables. It complements existing joint-and multiple-testing methods that are based on ex-ante curation by the researcher.
Introduction
In this paper, we propose a data-driven approach rooted in machine learning to the problem of testing effects on groups of outcome variables. A core challenge in the analysis of experimental data is that the impact of some intervention is often not entirely captured by a single, well-defined outcome. Instead we may have a large number of outcome variables that are potentially affected and of interest. In some of these cases, we may have a sense for which of these different outcomes we hope to document an effect, and face a multiple or joint testing problem in integrating individual tests. In other cases, some abstract outcome we are interested in, such as 'health', may not even be measured directly and requires us to pick and combine measures relevant to the key underlying concept. In either case we need some way to aggregate evidence across variables to see whether there is an effect (that is, whether the effects on the group of outcomes is jointly zero or not). Getting this aggregation right is central to whether we can trust conclusions derived from experiments with many outcomes.
Existing techniques fall into some combination of two approaches. One approach involves estimating mean differences for individual outcome variables, which are aggregated with an adjustment for the number of test statistics formed. For example Bonferroni-like adjustments (Bonferroni, 1936; Dunn, 1961; Holm, 1979; Benjamini and Hochberg, 1995; Romano and Wolf, 2005) correct for the multiple tests performed, while joint tests in seemingly unrelated linear regressions are based on critical values that scale with the dimensionality of the data. A second approach involves limiting the number of tests carried out, such as explicitly forming pre-analysis plans or implicitly relying on the pre-specification of what will be tested. For example, one might specify how a set of variables will be collapsed into a 'health' index and the test will be on that index. These two approaches are complementary and often used in conjunction.
Both methods rely heavily on one's priors. Common multiple or joint testing procedures place penalties (as they should) on running many tests. Pre-specification and indices require one to decide ahead of time where to search for signal. In short, standard methods place restrictive assumptions on the nature and location within the outcome space of the treatment effect in order to control the risk of false positives. Having run a large experiment, often at great expense of both money and time, this constraint is often costly: it practically means that one can only look for treatment effects in a few places.
The machine learning approach we propose here complements existing joint-and multipletesting methods that are based on ex-ante curation by the researcher. It is based on two simple observations. First, the 'false-positive' problem that a group of outcomes poses can be thought of finding something in a given experiment that is idiosyncratic to that sample, rather than a true feature of the underlying data-generating process. Put this way, we can see that the general structure of this concern is similar to the concern within machine learning of 'over-fitting,' which has been the focus of a large literature in statistics and computer science. We can thus leverage sample-splitting methods from the machine-learning playbook that are designed to control over-fitting to ensure that statistical models express generalizable insights about treatment effects.
The second simple observation is that the question of whether treatment T (say binary) affects a group of variables Y = (Y 1 , ..., Y k ) in an experiment is equivalent to the question whether T is predictable using Y (better than some trivial benchmark). In the parlance of Kleinberg et al. (2015) and Mullainathan and Spiess (2017) , this simple observation turns multiple testing into a prediction task ("ŷ problem"). Predictability takes the place of a treatment effect on the full distribution of outcomes. This formulation allows us to leverage data-driven predictors from the machine-learning literature to flexibly mine for effects, rather than rely on more rigid approaches like multiple-testing corrections and pre-analysis plans. 1
We formulate a specific methodology and present three kinds of results. First, we show that, for any samples size, our test produces a p-value that is exactly sized under the null hypothesis of jointly no effect on the group of outcomes. Second, we give qualitative reasons for why our test compares favorably to standard testing procedures. In particular, we show that a version of our prediction test can -at least asymptotically -be understood as nesting standard tests based on mean comparisons, while doing better when there are considerable non-linear effects on the outcomes. Third, we discuss how we can use our procedure to learn something about where any effect happens for purposes like testing theories or benefit-cost analyses of specific interventions. 2 Finally, we describe how the test can deal with typical features of real-world experiments, namely missing data, conditional or clustered randomization, and stratification. In addition, we show how our approach can be adapted to balance checks, a data-driven analysis of attrition, and a test of dominance of treatment over control under minimal assumptions on choice.
We set up the many-outcomes problem in Section 2. In Section 3, we review some standard approaches, and discuss their applicability in selected economic examples. Section 4 presents our prediction procedure and analyzes its properties. In Section 5, we present some ideas on interpreting the prediction output. Section 6 illustrates our approach on simulated data. In Section 7, we conclude by discussing challenges from typical features of real-world experiments and extensions to balance checks.
1 In framing the many-outcomes problem as testing whether two distributions are the same, we relate our work to the general two-sample problem, in particular recent non-parametric approaches based on kernels (Gretton et al., 2007) . In terms of using a prediction approach to the two-sample problem, we are building on a classic literature in economics and econometrics that studies discrimination using reverse regressions (as discussed e.g. by Goldberger, 1984) . As part of our procedure, we will propose a permutation test to obtain a valid p-value, paralleling recent uses of omnibus permutation tests and randomization inference in the evaluation of experiments (Potter and Griffiths, 2006; Ding et al., 2015; Chetty et al., 2016; Young, 2016) .
2 In terms of typical applications, our research is related to multiple testing procedures based on individual mean comparison tests. Multiple testing procedures control the overall probability of at least on false positive (family-wise error rate) or the proportions of false positives among all rejections (false discovery rate, Benjamini and Hochberg, 1995) . The most prominent such procedure, the Bonferroni correction (Bonferroni, 1936; Dunn, 1961) , and its Holm (1979) step-wise improvement, ignore the correlation between individual test statistics. Other, more recent procedures take the dependence structure of test statistics into account, for example the step-wise procedure by Romano and Wolf (2005) ; most closely related to our framework, List et al. (2016) propose a bootstrap-based adaption to experiments.
We consider the problem of testing whether a group of outcomes variables is affected in an experiment. Assume we have a sample of n iid observations (T i , Y i ), with binary treatment T i assigned randomly. Randomization may be by clusters of observation and within some strata.
We have a group of k scalar outcomes:
Our primary goal is to test whether treatment has an effect on this group of outcomes, that is, whether the distributions of Y i |T i = 1 is the same as the distribution of Y i |T i = 0. If, for example, the two distributions differ only by a (k-dimensional) mean shift by τ = (τ 1 , . . . , τ k ) , our null hypothesis of interest is τ j = 0 for all j simultaneously. (If our concern was to test baseline balance instead, the available pre-treatment covariates would take on the role of outcome variables.)
A related but different question is whether there are effects on the individual outcome variables Y ij . This question can be useful for testing a specific theory, or if researchers have a clear sense of which individual outcome variable is of central interest. But often this question is complementary to the testing the joint hypothesis of no effect on any outcome. Having run a complex and expensive trial, a minimal first-pass question is commonly to ask the question "Did the experiment have any effect at all?" Tests of this joint hypothesis can be useful even when researchers are interested in a single specific hypothesis, for example when we do not know how to convert a specific hypothesis into individual variables (such as "health" being measured via numerous outcomes).
Standard Approaches and their Mapping to Applications
In this section we consider the standard approaches to testing whether treatment has an effect on multiple outcomes. Standard approaches fall into two broad categories: Tests based on mean comparisons of the outcomes, such as a Wald test in a seemingly unrelated regression (SUR) of the outcomes on the treatment dummy; and tests based on a pre-defined index, where we aggregate all outcomes (usually linearly) into a single index and run one test on the treatment-control mean difference for this index (e.g. Kling et al., 2007, web appendix) . We begin by considering the implicit assumptions behind these standard approaches. We then consider how these assumptions fare when confronted with the range of applications that experimental economists may encounter in practice.
Standard Testing Approaches
We first consider the assumptions behind tests of effects on a group of outcomes that are based on aggregating the results of individual mean-comparison tests. Before we consider the aggregation of mean values, it is useful to first focus on the means tests themselves.
To simplify the exposition we consider a simple class of data-generating processes. For outcome j, write
where the control baseline C j is constant, while the treatment effect τ j and the mean-zero error term j are random and possibly correlated both within and between outcomes, but independent of treatment assignment T j . For simplicity, we assume here that the τ j and j are jointly Normally distributed. Our goal is to test whether treatment and control distributions are the same -that is, whether τ j = 0 for all j. What would be an appropriate test for the null hypothesis?
Many standard approaches are based on individual mean comparisons, that is, they estimate the individual mean differences and then aggregate those to test that all mean differences are simultaneously zero. If the variances were different between treatment and control groups, testing for τ j = 0 by only testing means would potentially leave information about different spreads on the table, no matter how we aggregate between individual mean estimates. If we base our inference solely on mean comparisons, we thus implicitly assume that mainly the means are affected by the intervention.
Individual means tests alone do not directly provide a rejection criterion for the overall null hypothesis of no effect on the full group of outcomes; to obtain the latter, we need to aggregate individual estimates while ensuring that our test is properly sized (that is, that the probability of rejecting the null hypothesis does not exceed the desired level when there is indeed no effect on the outcomes). A particular simple form a aggregation are multiple comparison test that aggregate the p-values p 1 , . . . , p k that come from the individual tests (in the case of treatment-control difference typically individual t-tests). A standard aggregation procedure that is sometimes used to test the joint null hypothesis of no effect on a group of outcomes because of the simplicity of its implementation is the Bonferroni correction (Bonferroni, 1936; Dunn, 1961) : Only reject the null hypothesis of no effect at all if one of the p-values is smaller than α/k, where α is the size of the test (typically α = 5%) and k is the number of outcomes. 3 Improvements over these classical methods perform step-wise corrections that take into account the overall distribution of p-values (Holm, 1979) and/or the correlation between test statistics (Romano and Wolf, 2005) .
When would a procedure like the Bonferroni-corrected multiple-comparison test be appropriate?
To understand how multiple-testing correction procedures perform in our application to the manyoutcomes problem, it is important to understand that they are designed as an answer to a different question: when they reject the overall null hypothesis of no effect, they also provide rejections of individual hypothesis that are informative about which of the outcomes is affected by treatment.
This additional information, however comes at a cost; in particular with many outcomes, multipletesting corrections tend to be conservative, and a direct test of the joint hypothesis of no overall effect is a more efficient answer to the question we are asking in this paper.
Beyond being limited to pre-specified means tests and paying a cost for providing individual rejections, Bonferroni-type corrections are inefficient in another way: Since they maps individual (valid) p-values p 1 , . . . , p k from mean comparisons to an overall p-value without taking into account the correlations between test statistics, they are typically not both valid (that is, have size bounded by the nominal size) and optimal (that is, not be dominated by some other test across alternative hypotheses) without restrictions on the between-outcome covariance structure of the τ j and j . In particular:
1. The Bonferroni correction (or its more powerful Holm (1979) stepwise version), which compares individual p-values against α/k, is strictly conservative (has size smaller than nominal size) and inefficient under any correlation structure, and has maximal size only if τ j and j are independent between outcomes.
2. The (more powerful)Šidák (1967) correction, which compares individual p-values against (1− α) 1/k , is valid, but strictly conservative unless τ j and j are independent between outcomes. 4 Here, we assume that the equal-variance assumption from above holds, and that p-values are obtained from two-sided t-tests.
Since such aggregation procedures do not use the information contained in the correlation of test statistics, they cannot generally be adequate, motivating variants that take the joint dependence structure of test statistics into account (Romano and Wolf, 2005) . The two specific tests have largest size (although Bonferroni is still inefficient) for independent error terms and treatment effects between outcomes. This assumption means that outcomes are independent conditional on treatment assignment (only covary through the treatment), as expressed in the graphical model in Figure 1 .
In applications in which all outcomes belong to a group, we typically assume them to be (conditionally) correlated, for example because they represent different aspects of one or more abstract (latent) outcomes that are affected by treatment. In this case, we may want to aggregate individual outcomes to one (or a few) aggregate outcomes on which we then perform means tests, rather than aggregating many test with a multiple-testing correction. As an extreme case, assume we know how the outcomes are related, and that this relationship is through a single latent variable:
... 
the (Normal) distribution of which only differs between treatment and control by a mean shift, so in our Normal framework Var(µ + δ) = Var(δ) (that is, the data is as if the treatment effect µ on L is constant). If we write Y j = C j + λ j L + η j with fixed known treatment effect λ j and independent Normal mean-zero error terms with known variance ν 2 j , then the linear index
is optimal in the sense that a Normal-theory means test on I is an adequate test of the null hypothesis that treatment and control distributions are the same (µ = 0).
If all correlation stems from one latent linear factor, and the treatment only operates through this factor, the outcomes are independent conditionally on this factor (Figure 2 ). In this case, an index (which estimates this latent factor) yields an adequate test by weighting each outcome by its signal-to-noise ratio.
The above linear index aggregates outcomes efficiently into a single test statistic provided that:
1. The correlation structure is simple (in our example given by a single latent linear factor); and 2. The relationships of outcomes to the latent factor are known ex-ante.
... The intuition behind this result is straightforward: If the test comes from a regression that is correctly specified, it is adequate. If the two distributions, on the other hand, differ in more than their means, this specific regression is misspecified, and a test that also tests the effect on variances or correlations between outcomes may have higher power.
Note that we do not require that individual outcomes are conditionally independent -indeed, the SUR-based test can correct for correlation between the test statistics. However, the structural
...
Figure 3: Conditional independence of latent variables assumptions we put on the test to show efficiency imply that the outcomes are only affected by treatment through constant treatment effects on at most k latent variables that are independent conditional on treatment (Figure 3) . We can thus think of the correction that SUR makes in constructing a test statistic as running the test not on the observed, correlated variables, but instead on the underlying (conditionally) uncorrelated latent factors L j , each of which is affected by the treatment through a mean shift, and then aggregating these independent test statistics efficiently.
Economic Examples
So how do the structures assumed by standard approaches to testing effects on a group of outcomes map into economic applications of the sort encountered by experimental economists in actual data applications? We discuss several hypothetical models that are intended to be quite simple in their structure and yet sufficient to highlight the difficulty with which standard methods will be able to capture even this simple structure.
Example 1 (Breaking a Causal Link). Assume that a health intervention tries to reduce the risk that high blood pressure leads to a heart attack-that is, it targets the link between hypertension and heart attack. Given data (T i , Y iA , Y iB ) on treatment (assumed random), heart attacks, and blood pressure, how do we test whether the intervention has an effect? If we test whether there is an overall effect of the intervention by running individual test on mean effects (multiple testing), and then aggregate the results using a Bonferroni correction to avoid false positives, including blood pressure data may reduce, rather than increase power, as it does not add additional independent information, but forces us to correct for the additional test. Even if there is some effect on blood pressure, a Bonferroni test would remain inefficient given the likely correlation between both test statistics.
While a joint test like SUR would correct for these correlations, it remains limited on a more fundamental level because it only considers the impact on means. While not reducing power, Y B would at least not help SUR.
But there is meaningful information in blood pressure Y B that can help to increase the power of the test: Indeed, it is in the link between both variables where the effect of the intervention becomes most apparent -while in the control group those with higher blood pressure have more heart attacks, this link may be broken among the treated, as people with high blood pressure but without heart attack incidence represent the clearest evidence of an effect.
Example 2 (Creating a Correlation). Consider the effect of health insurance. Assume that there is some acute condition, say back pain, and some chronic condition, say some heart disease that leads to heart attack if not discovered and treated. If a person gets hospitalized because of back pain, we hypothesize that health insurance increases their propensity to then also get checked (and treated if necessary) for heart disease. Given data (T i , Y iA , Y iB ) on treatment (assumed random), heart attacks, and back pain (which leads to hospitalizations H i ), how do we best test whether the intervention has an effect on health outcomes?
Example 3 (Budget Constraint). Consider the effect of a cash grant, which we hypothesize increases the amount of money spent on education and health. However, every additional dollar spent on education or health can only be spent on one of these, moderated by the (unobserved) propensity of spending on one over the other.
Given data (T i , Y iH , Y iE ) on treatment (assumed random), health spending, and education spending (but not on the unobserved spending M i on health and education combined and individual propensity P i to spend on health versus education), how do we best test whether the intervention has an effect?
Example 4 (On a Causal Chain). Consider the effect of an intervention that encourages preventive care on short-and long-run health outcomes. For example, statins (a preventive intervention) reduce cholesterol levels (a short-run outcome), which are associated with cardiovascular disease (a long-run outcome). Given data (T i , Y iC , Y iA ) on treatment (assumed random), cholesterol levels (affected by statins take-up S), and heart attack, how do we best test whether neighborhoods have an effect?
Example 5 (Two Paths to Success). Consider the effect of moving to a new neighbourhood, which has potential effects both on parents' earnings and school quality -directly through the availability of schools, and indirectly through the parents' ability to afford a better school. Given data (T i , Y iE , Y iS ) on treatment (assumed random), parents' earnings, and education outcomes (as a proxy for unobserved school quality Q i ), how do we best test whether neighborhoods have
Take-Aways from Examples and Standard Approaches
In these examples, standard approaches leave information on the table, as they are misspecified for the economics of the situation. Each asks us to anticipate the effects we expect to see, but hardly any of the assumptions that justify the above tests maps well into the structure we have presented.
There are two ways to go from here: First, we could try to build the right test for the right situation, using case-specific knowledge and theory to guide which structural assumptions we feel comfortable with each time and how we go about exploiting this structure by creating an appropriate set of individual hypotheses; or second, we could be agnostic about the specific structure and instead leverage tools -such as those provided by machine learning -that are able to adapt flexibly to any given dataset, and thereby explode the number of individual hypotheses they search over. We take this second path.
Prediction Approach
We turn the basic null hypothesis -"the distribution of outcomes is the same in treatment in control" -into a prediction statement: "treatment status is not predictable from the outcomes".
We thus aim to predict T from Y using a flexible prediction function; if we find a function that predicts treatment status significantly better than chance, we have evidence of a difference between the two distributions. Following Kleinberg et al. (2015) and Mullainathan and Spiess (2017) , this turns the testing task into a "ŷ problem" -which in this case really is a "T problem".
The workhorse of our testing procedure will thus be a prediction function: It takes as input a sample of treatment assignment and outcomes, and constructs from this sample a prediction function that maps values of the outcomes to the probability of being in the treatment group. The better this prediction is -that is, the lower the discrepancy between the predicted probabilities and realized treatment assignment -the better the evidence that treatment and control groups are different.
One advantage of re-framing the group outcomes problem into one of prediction is that it enables us to take advantage of machine-learning approaches that are capable of considering very complicated functional forms. Moreover we can use the machinery of machine learning that guards against over-fitting in standard prediction applications to help find effects in a given experiment that reflect real underlying structure, rather than simply being artifacts of a particular sample.
Formal Framework
To lay out our testing procedure, we make minimal assumptions on the data-generating process and the prediction function: -Random sample from RCT. We have a sample
of n iid observations (T i , Y i ), with binary treatment T i assigned randomly (as in Section 2).
-Black-box prediction algorithm. We have a prediction algorithm A that takes as input a similar (but possibly smaller) sampleS of size m ≤ n, and outputs a prediction function
While not formally required for our results until later, we assume that the functionf is chosen to yield low out-of-sample loss
for some loss function : (T , T ) → (T , T ) ∈ R; for most of this paper, we will assume that this is squared-error loss,
but most results would go through for other well-behaved loss functions as well, such as the negative log-likelihood (T , T ) = −(T log(T ) + (1 − T ) log(1 −T )). 6
6 Indeed, the negative log-likelihood offers an alternative justification for our approach, and shows its generality: If instead we fitted a model p θ (t, y) = p θ (t|y)p θ (y) of the distribution of (T, Y ) and assumed that p θ (t, y) = p θ 1 (t|y)p θ 2 (y) with Θ = Θ1 × Θ2,then the null hypothesis of equal conditional distributions, p θ (y|t = 1) = p θ (y|t = 0) a.s., would translate into p θ 1 (t|y) = p θ 1 (t) a.s. Since the log-likelihood would factorize as log p θ (t, y) = log p θ 1 (t|y) + log p θ 2 (y), a conditional likelihood ratio test with p θ 1 (t|y) would be equivalent to a likelihood ratio test with the full model. This conditional likelihood ratio test is a prediction test withf (Y ) = pθ 1 (1|Y ) and the negative log-likelihood as loss.
formal statements of its econometric properties. The validity of the test will not require any additional assumptions; for efficiency, we will assume more structure both about the data-generating process and the prediction technology.
Note that we intentionally do not restrict the class of algorithms for now and do not even formally require that they minimize out-of-sample loss L(f ) over some class of functions. This is to lay bare the relationship between prediction (of any quality) and the underlying hypothesis testing problem. Practically, of course, the power of our testing procedure comes from the existence of machine learning algorithms A that produce low out-of-sample prediction loss L(f ). As a result, when we prove formal statements about the power of our procedure, we will make further assumptions.
Testing Procedure
The basis of our test is simple: compute out-of-sample lossL in predicting treatment T from Y ; compute the distribution of out-of-sample loss under the null of no treatment effect (where T cannot be predicted from Y at all); and form a test based on whereL falls in this distribution.
Since in-sample loss is a biased measure of out-of-sample performance (the function may look good in-sample through overfitting, even if there is no signal), and since we do not want to restrict prediction algorithms to those few for which we know how to estimate out-of-sample loss from in-sample loss, we rely on sample-splitting methods in evaluating loss: we never fit a function on the same data that we evaluate it on.
The first variant applies this idea in the most straightforward way:
(H) Hold-out test: Split the sample randomly into a training sample S T of size m and a hold-out sample S H of size n − m. Obtain a prediction function
from the training sample. On the hold-out sample S H , calculate predicted valuesT i =f T (Y i ) and test whether the losŝ
is significantly better than if T were unrelated to Y (more on that below).
Note that this hold-out strategy ensures that all predictions are out-of-sample; however, it has an obvious inefficiency, as only a fraction of datapoints is used to fit the function -and only a fraction is used to test its fit. This is corrected by our second variant, which uses every datapoint once for evaluating loss, and multiple times for fitting:
(CV) Cross-validation test: Split the sample randomly into K equally-sized folds S 1 , . . . , S K (of size approximately n/K each). For every J ∈ {1, . . . , K}, obtain a prediction function
from all other folds, and calculate predicted valuesT i =f J (Y i ) on fold S J . Test whether the
is significantly better than if T were unrelated to Y on the full sample. 7
This procedure thus predicts K times from m = n − n/K datapoints; for K = n (leave-one-out), the sample size of each training sample is maximal at m = n − 1.
Obtaining a p-value. Given a loss estimate, how do we obtain a p-value for the null hypothesis that the distribution of outcomes is not affected by the treatment?
We rely on sample-splitting methods and restrict ourselves to evaluating out-of-sample loss because we want to be agnostic about the algorithm used for prediction -after all, we want to allow for complex machine-learning algorithms that may not fit our usual analytical estimation frameworks. For the same reason, we want to obtain a valid test under minimal assumptions. We therefore propose a permutation test:
(H) For the hold-out design, permute treatment assignment randomly within the hold-out sample to obtain loss estimatesL
The p-value is the quantile of lossL within the distribution ofL π .
(CV) For the cross-validation design, permute treatment assignment randomly across the full sample, re-estimate all prediction functions, and obtain loss estimatesL π . The p-value is the quantile of lossL within the distribution ofL π .
The logic behind the permutation test is straightforward: If the null hypothesis is true, the data with permuted treatment assignment looks just like the original sample; if, to the contrary, we can predict better from the actual sample, this is evidence for a treatment effect. Crucially, this logic does not depend on any specific feature of the data-generating process or the algorithm, but it reflects the strength of the null hypothesis.
Note that the hold-out test does not require the re-estimation of prediction functions in every run; the cross-validation scheme, on the other hand, refits K prediction function for every permutation draw. 8 We see the main disadvantage of the cross-validation procedure over the holdout procedure as being much more computationally costly -both because of repeated predictions for one sample and re-estimation for every permutation -but note all predictions can be computed in parallel.
Econometric Analysis
We start with an analysis of our testing procedure under the minimal assumptions from Section 4.1.
By construction, the hold-out and K-fold permutation test have exact size (provided appropriate interpolation to form the p-value):
Claim 1 (Exact Size of H and CV tests). The hold-out test and the K-fold permutation test that reject the null hypothesis (that treatment assignment is independent of the outcomes) whenever p < α has (exactly) size α, for any nominal level α and sample size n.
Note that we did not make any assumptions about the prediction algorithm; in particular, the tests have exact size even for complex machine-learning prediction algorithms.
When deciding whether to employ the above testing procedure, we care not just about size, but also power. In particular, we may be worried that we lose efficiency relative to a standard joint test based on mean differences in cases in which the effect is exclusively on the means of the outcomes, or relatively to a prediction-based test that uses the full sample and corrects for overfitting analytically.
Towards efficiency, we first show asymptotic equivalence if we restrict ourselves to linear predictors, where the data comes from a linear model with Normal, homoscedastic errors:
Assumption 1 (All Effects are Mean Shifts). Assume that the data is generated by Y = C + τ n T + where (1.1) T independent of , (1.2) T has fixed distribution (across n) with p = ET ∈ (0, 1),
(1.4) ∼ N (0, Σ) with Σ symmetric and positive-definite, (1.5) C is a constant vector, (1.6) treatment effects are local to zero with τ n = τ 1 / √ n, where τ 1 is a constant vector.
We formulate these specific conditions because they represent a world in which a linear SUR is correctly specified and the corresponding Wald test is a natural test for the joint hypothesis of no effect. Indeed, these assumptions ensure that the full treatment effect is captured by mean shifts in the individual outcome dimensions. The normalization (1.6) provides that asymptotic power does not take off to one asymptotically. We claim that the following equivalence results holds under these conditions:
Claim 2 (Asymptotic Equivalence of Linear Tests). Under Assumption 1, the following tests are asymptotically equivalent in the sense that their power converges to the same limit:
2. An F -(goodness-of-fit) or χ 2 -test (Wald test) in an in-sample linear regression of T on Y ;
3. The K-fold permutation test with linear least-squares prediction function and squarederror loss for K = n (leave-one-out).
A precise statement of this and all following results will be found in the Appendix.
Hence, as long as we use the linear-least squares estimator as a predictor, we do not asymptotically lose any power from putting the outcomes on the right-hand side of the regression, or from running a cross-validation permutation test. In particular, there is no (asymptotic) loss from using the prediction test with a linear predictor relative to a standard test based on pairwise comparisons.
While these results are reassuring, we motivated our prediction procedure through more flexible functional forms. So what happens if OLS is not correctly specified, and a more flexible algorithm will find additional structure?
Claim 3 (Asymptotic Dominance of Better Predictor). If the algorithm A recovers more information in the limit than a trivial predictor in the sense that
then, if the prediction algorithm is well-behaved in the sense that
and under appropriate regularity conditions on the sequence of data-generating processes, the K-fold and hold-out tests -using the algorithm A directly or inside an ensemble -have power approaching one. In particular, unless the Wald test in linear regression also has power converging to one (or OLS as a predictor recovers more predictive information in the limit than a trivial predictor), the test based on the more predictive algorithm has power asymptotically strictly larger than the linear Wald test (or a prediction test with linear regression).
This result is merely a formalization of the intuition we started our inquiry with: If our predictor picks up structure that is not linear, and that corresponds to a definite loss improvement in the large-sample limit, then it will ultimately reject the null hypothesis of no treatment effect, while a linear-based test may achieve strictly smaller power.
Interpreting the Prediction Output
The above test gives us a p-value for the null hypothesis that there is no difference in outcome distribution between treatment and control groups, based on a prediction task. However, we may also be interested in what the effect is on -that is, where in the outcome space the prediction algorithm found signal about treatment. This is relevant for using experiments to test economic theories, which often generate testable implications about which outcomes should and should not be affected in an experiment, and for carrying out benefit-cost analyses of specific interventions.
However, with machine-learning techniques this is more complicated than just testing for an overall effect on a group of outcomes -that is, testing whether treatment assignment is predictable. The reason is that machine learning tools are designed to generate good out-of-sample predictions by extracting as much signal as possible from the explanatory variables, rather than to isolate the individual relationships of each predictor with the left-hand side variable. In this section we discuss how we navigate this constraint.
Index Interpretation
A prediction function of treatment assignment from the outcomes is itself a functionf (Y ) of the outcomes Y , and thus an index. Indeed, we can interpret the prediction exercise with respect to squared-error loss as the estimation of an optimal index:
Remark 3 (Optimal Index Interpretation). The prediction function that minimizes squarederror loss within a given class of functions is also the function within that class with the maximal mean treatment-control difference (for a given mean and variance).
When we choose a prediction function, we thus also estimate an optimal index -where "optimal" refers to it being maximally different between treatment and control. This mean difference also offers an quantification of the difference between the distributions.
Analyzing the Difference Between the Two Distributions
If we are not just interested in whether there is an effect at all (expressed by said p-value), but also where it is, we can use the predicted treatment assignment valuesT i obtained within the holdout or K-fold testing procedure as a guide to where the two distributions differ; in particular, for standard loss functions,T can be seen as estimating P(T = 1|Y ), as P(T = 1|Y ) is the prediction minimizing squared-error loss and maximizing the likelihood.
To obtain summary statistics of the difference in distributions expressed by these predicted values, we can calculate the implied treatment effect on any function of the outcome vector (including a given index), such as the outcomes vector itself:
While primarily an expression of the treatment effect expressed by the prediction function, it becomes an estimate of the average treatment effect vector τ = E(Y |T = 1) − E(Y |T = 0) provided that the prediction function is loss-consistent (where loss is assumed to be out-of-sample squarederror loss of the algorithm throughout):
Claim 4 (Loss Consistency Implies Estimation Consistency). If the predictor is loss-consistent,
where L * = L(f * ) is the loss from the optimal predictor f * (Y ) = E(T |Y ), then, under regularity conditions,τT
Note that this result can be extended to the effect on any fixed function g(Y ) of the outcomes.
Similar results can be achieved for expectations of functions h(Y, P(T = 1|Y )) that are estimated by the average of h(Y,T ).
Simulation Example
As an illustration and to calibrate power, we provide a simulation example with k = 2 outcomes based on the data-generating process
with two-dimensional standard Normal, where m ("move") and s ("stretch") are both scalar parameters: m moves the treated distribution towards the north-east (relative to the control distribution, which is centered at the origin) and s stretches the variance of the treated distribution equally in all directions (relative to the control distribution, which has rotation-invariant unit variance). We assume that P(T = 1) = .5 throughout. In this setting, the null hypothesis of no effect (same distributions) corresponds to m = 0 = s. For different values of the parameters, we study the power of a test of this null hypothesis from samples of size n = 100.
We compare two test for no overall effect of treatment:
-A Wald test based on a linear regression (SUR) of (Y 1 , Y 2 ) on T ; this test is based on a correctly specified regression for no stretch (s = 0), but cannot detect changes in the variance between treatment and control (s = 0).
-A 5-fold prediction permutation test as described above, with an ensemble of linear regression (T on Y 1 , Y 2 and constant) and a random forest of 100 trees, tuned using 5-fold cross-validation along the number of variables considered in tree splits and the minimal number of units in a node; the weights for the ensemble are chosen in-sample to minimize the loss of a convex combination of out-of-sample predictions from both predictors.
As an illustration, Figure 9 presents the data and fitted ensemble predictions for one draw from this data-generating process with moderate move (m = 0.2) and considerable stretch (s = 0.5). For this draw, the predicted valuesT i correctly locate the lower density of treatment in the lower-left quadrant and the higher density in the periphery ( Figure 9a) ; the permutation test produces a In the framework of linear regression of Y 1 , Y 2 on T , higher stretch only adds variance and thus decreases power; for the prediction test, on the other hand, differential variance between control and treatment provides evidence of an effect and thus increases the rejection rate.
The results in Table 1 
Extensions
We have presented a specific methodology that allows for the leverage of powerful machine-learning predictors to test for the effect of a randomized intervention on a group of outcome variables. We note that our methodology can be adopted for cluster randomization (by splitting and permuting data by clusters), stratified/conditional (within-site) randomization (by splitting and permuting within strata/sites), and missing data (e.g. by testing whether the outcomes predict treatment assignment better than missingness information alone). Apart from testing for the effect on multiple outcomes, another natural application is the test for baseline balance, where pre-treatment covariates take the role of outcomes, and the null hypothesis is that there is no statistical difference between treatment and control characteristics at baseline.
